These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24587616)

  • 1. Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications.
    Martinez JO; Brown BS; Quattrocchi N; Evangelopoulos M; Ferrari M; Tasciotti E
    Chin Sci Bull; 2012 Nov; 57(31):3961-3971. PubMed ID: 24587616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
    Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature.
    Karabasz A; Bzowska M; Szczepanowicz K
    Int J Nanomedicine; 2020; 15():8673-8696. PubMed ID: 33192061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinations of chemo-, immuno-, and gene therapies using nanocarriers as a multifunctional drug platform.
    Hopkins C; Javius-Jones K; Wang Y; Hong H; Hu Q; Hong S
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1337-1349. PubMed ID: 35949105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging methods in therapeutics using multifunctional nanoparticles.
    Habibi N; Quevedo DF; Gregory JV; Lahann J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1625. PubMed ID: 32196991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light-activatable gold nanoshells for drug delivery applications.
    Singhana B; Slattery P; Chen A; Wallace M; Melancon MP
    AAPS PharmSciTech; 2014 Jun; 15(3):741-52. PubMed ID: 24550102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
    Majumder J; Minko T
    Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An insight into the dual role of MoS2-based nanocarriers in anticancer drug delivery and therapy.
    Ghosh S; Lai JY
    Acta Biomater; 2024 Apr; 179():36-60. PubMed ID: 38552760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Biomedical Applications of Multifunctional Nanoparticles.
    Kim D; Shin K; Kwon SG; Hyeon T
    Adv Mater; 2018 Dec; 30(49):e1802309. PubMed ID: 30133009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment.
    Milewska S; Niemirowicz-Laskowska K; Siemiaszko G; Nowicki P; Wilczewska AZ; Car H
    Int J Nanomedicine; 2021; 16():6593-6644. PubMed ID: 34611400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-drug delivery system for the treatment of acute myelogenous leukemia.
    Zhang S; Sun J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):233-240. PubMed ID: 35713321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers.
    Sharifi S; Caracciolo G; Mahmoudi M
    Trends Pharmacol Sci; 2020 Sep; 41(9):641-652. PubMed ID: 32713606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Synergistic Effect of Nanoparticles and Its Biomedical Application.
    Nanda SS; Yi DK
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.